Globalworth starts new office development in Bucharest

Business Forum
Globalworth Romania has begun construction of Green Court D, the fourth building in the Green Court complex in Bucharest's Aurel Vlaicu area. The project is scheduled for completion in 2027 and is currently in the preliminary construction stage involving enclosure and basement excavations.

The building will offer approximately 16,500 sqm of office space across ground floor and 11 upper floors, with three underground parking levels. The project has already secured a 30% pre-lease rate.

"Our latest project, Green Court D, combines state-of-the-art technology and green solutions with sophisticated and comfortable spaces, strengthening Globalworth's position as the largest business community in Romania," said Ema Iftimie, Managing Director of Globalworth Romania.

Green Court D will feature a geothermal system with 19 wells drilled at 125m depth, heat pumps, air-cooled chillers using environmentally friendly refrigerant, and air handling units with heat recovery systems. The building will include a 168 kWp photovoltaic installation, full LED lighting, and EC-motor fan coils for enhanced efficiency.

The building is targeting LEED Platinum certification along with WELL Health & Safety and Access4you certifications. During H1 2025, Globalworth Romania invested approximately €20 million in improvement initiatives across its existing portfolio to increase efficiency and reduce emissions.

RECOMMENDED
What the surge in technical services demand means for property investments in 2026
Real estate

What the surge in technical services demand means for property investments in 2026

Andrei Ianculescu, Head of Project & Development Services at Cushman & Wakefield Echinox, talked to Property Forum about the expansion of design and ESG advisory services, the industrial and logistics sector's growth post-Schengen, and the importance of independent project management for tenant fit-outs. Ianculescu also emphasised the potential in secondary cities and the increasing relevance of aligning projects with sustainability standards.

Globalworth renews Access4you certification for entire Romanian portfolio
Real estate

Globalworth renews Access4you certification for entire Romanian portfolio

Globalworth has renewed its Access4you certification for all 16 office buildings in its Romanian portfolio, totaling almost 500,000 sqm. The recertification, conducted with consultancy services from Colliers, marks the second three-year certification cycle for the leading office investor in CEE.

GTCs City Gate secures LEED Gold v5 certification
Real estate

GTC's City Gate secures LEED Gold v5 certification

The South Tower of City Gate in Bucharest, developed and managed by GTC, has been awarded the LEED Gold v5 certificate. This is the latest version of the world's green building standard, outlining steps towards near-zero carbon emissions, prioritizing people, and supporting building resilience. City Gate is the first property in Romania and only the fourth existing building in Europe to achieve this recognition, following projects in Italy, Spain, and Sweden.

FDI in Romanian real estate triples in past decade
Real estate

FDI in Romanian real estate triples in past decade

Foreign direct investments (FDI) in Romania's real estate and construction sector more than tripled between 2014 and 2024, increasing by €15.1 billion to reach €21.6 billion by the end of last year. The sector's share of total FDI stock rose from 10.6% to 17.3%, according to National Bank of Romania (BNR) data analyzed by Cushman & Wakefield Echinox.

RECOMMENDED FROM THE HOME PAGE
CCE sells major solar project in Romania
Energy

CCE sells major solar project in Romania

CMS has advised CCE on the sale of Horia Solar Invest Two, a special purpose vehicle developing a 269.227 MW (AC)/ 293.260 MWp solar project spanning more than 349 hectares in Arad County (Horia 2), to Renalfa Solarpro Group.

Industry

Life sciences M&A surges 81% as big pharma hunts for growth, says EY

Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.

READ MORE
Business Forum  |  19 January, 2026 at 12:06 PM
Business Forum  |  19 January, 2026 at 10:14 AM